The Ident-A-Drug reference allows officers to identify tablets and capsules by imprint code from more than 33,000 listings. The reference gives you exact DEA narcotic classifications and physical ...
The Centers for Medicare & Medicaid Services ("CMS") has finalized the Global Benchmark for Efficient Drug Pricing ("GLOBE") Model, which ties ...
Generic drugmakers have received finalized guidance from the US Food and Drug Administration. In finalizing a 2017 draft, the agency gives sponsors of abbreviated new drug applications (ANDAs) ...
Basing new drug launch prices on historical domestic data could limit manufacturers' power to set extremely high launch prices and could reduce Medicare spending on new drugs by up to 30%, according ...
The US Food and Drug Administration (FDA) is recommending drugs made by generic manufacturers closely mimic the physical attributes, including the size, shape and color, of the drugs they reference.
The Trump administration has proposed using international pricing of drugs to establish ceilings on what Medicare will pay for therapies administered by physicians in their offices or in hospital ...
Domestic reference pricing for remdesivir would consider the US launch prices of therapeutically similar drugs and adjust those prices for inflation and the presumed increased clinical innovation of ...
International reference pricing dodges critical drug value assessment issues and would lead to more inaction on high drug prices in the US. In contrast, most public-funded health care systems ...
Basing new drug launch prices on historical domestic data could limit manufacturers' power to set extremely high launch prices and could reduce Medicare spending on new drugs by up to 30%, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results